Focus: KinCon biolabs is a biotechnology company specializing in live-cell activity biosensors, a research tools and platform technology focused on enabling drug discovery and development workflows. The company operates from Innsbruck, Austria, but limited public data on scale and funding status is available.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow KinCon biolabs to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Help build intelligence for KinCon biolabs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from KinCon biolabs's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo